|
1.Arrossi S, Sankaranarayanan R, and Parkin DM. Incidence and mortality of cervical cancer in Latin America. Salud Publica Mex 2003; 45 Suppl 3:S306-14. 2.國民健康局. 衛生署資訊網 3.F.A Tavassoli, Peter Devilee, WHO classification of tumor:Tumours of the breast and female genital organs 4.Herzog TJ, Monk BJ. Reducing the burden of glandular carcinomas of the uterine cervix. Am J Obstet Gynecol 2007; 197:566-71 5.Solomon D, Nayar R, The Bethesda System for reporting cervical cytology. 2004, New York: Springer-Verlag. 6.Soost HJ, Lange HJ, Lehmacher W, et al. The validation of cervical cytology. Sensitivity, specificity and predictive values. Acta Cytol 1991; 35:8-14. 7.Davey E, Barratt A, Irwig L, et al. Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review. Lancet 2006; 367:122-32. 8.Ronco G, Cuzick J, Pierotti P, et al. Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial. BMJ 2007; 335:28. 9.Ogura K, Ishi K, Matsumoto T, et al. Human papillomavirus localization in cervical adenocarcinoma and adenosquamous carcinoma using in situ polymerase chain reaction: review of the literature of human papillomavirus detection in these carcinomas. Pathol Int 2006; 56:301-8. 10.Chen CA, Liu CY, Chou HH, et al. The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: A Taiwan Cooperative Oncologic Group Study. Int J Gynecol Cancer 2006; 16:1801-8. 11.Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003; 88:63-73. 12.Moberg M, Gustavsson I, and Gyllensten U. Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ. Int J Cancer 2004; 112:854-9. 13.Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348:518-27. 14.Giatromanolaki A, Sivridis E, Papazoglou D, et al. Human papillomavirus in endometrial adenocarcinomas: infectious agent or a mere "passenger"? Infect Dis Obstet Gynecol 2007; 2007:60549. 15.Brewster WR, Monk BJ, Burger RA, et al. Does human papillomavirus have a role in cancers of the uterine corpus? Gynecol Oncol 1999; 75:51-4. 16.Lai CH, Wang CY, Lin CY, et al. Detection of human papillomavirus RNA in ovarian and endometrial carcinomas by reverse transcription/polymerase chain reaction. Gynecol Obstet Invest 1994; 38:276-80. 17.Cecchini S, Palli D, and Casini A. Cervical intraepithelial neoplasia III. An estimate of screening error rates and optimal screening interval. Acta Cytol 1985; 29:329-33. 18.Coppleson LW, Brown B. Estimation of the screening error rate from the observed detection rates in repeated cercival cytology. Am J Obstet Gynecol 1974; 119:953-8. 19.May D. Error rates in cervical cytological screening tests. Br J Cancer 1974; 29:106-13. 20.van der Graaf Y, Vooijs GP, Gaillard HL, et al. Screening errors in cervical cytologic screening. Acta Cytol 1987; 31:434-8. 21.Lonky NM, Felix JC, Naidu YM, et al. Triage of atypical squamous cells of undetermined significance with hybrid capture II: colposcopy and histologic human papillomavirus correlation. Obstet Gynecol 2003; 101:481-9. 22.Ronco G, Giorgi-Rossi P, Carozzi F, et al. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst 2008; 100:492-501. 23.Meijer CJ, Berkhof J, Castle PE, et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer 2009; 124:516-20. 24.Behtash N, Nazari Z, Fakhrejahani F, et al. Clinical and histological significance of atypical glandular cell on Pap smear. Aust N Z J Obstet Gynaecol 2007; 47:46-9. 25.Lai CR, Hsu CY, Tsay SH, et al. Clinical significance of atypical glandular cells by the 2001 Bethesda System in cytohistologic correlation. Acta Cytol 2008; 52:563-7. 26.Thrall MJ, Kjeidahl KS, Savik K, Gulbahce HE, Pambuccian SE. Significance of benign endometrial cells in Papanicolaou Tests from women aged 940 years. Cancer Cytopathol 2005;105:207-16. 27.Chhieng DC, Elgert P, Cohen JM, Cangiarella JF. Clinical implications of atypical glandular cells of undetermined significance, favor endometrial origin. Cancer (Cancer Cytopathol) 2001;93:351-6. 28.DeMay RM. The Pap Smear. In: The Art and Science of Cytopathology. Chicago: ASCP Press, 1996:120-9 29.Raab SS, Snider TE, Potts SA, McDaniel HL, Robinson RA, Nelson DL, et al. Atypical glandular cells of undetermined significance: diagnostic accuracy and interobserver variability using select cytologic criteria. Am J Clin Pathol 1997;107:299-307. 30.Simsir A, Hwang S, Cangiarella J, Elgert P, Levine P, Sheffield MV, et al. Glandular cells atypical atypical on Papanicoloau smears: interobserver variabilitiy in the diagnosis and prediction of the cell of origin. Cancer (Cancer Cytopathol) 2003;99:323-30. 31.Cangiarella JF, Chhieng DC. Atypical glandular cells Van update. Diagn Cytopathol 2003;29:271-9 32.David L. Greenspan, Marina Cardillo, Diane D. Davey et al. Endometrial Cells in Cervical Cytology: Review of Cytological Features and Clinical Assessment .Journal of Lower Genital Tract Disease,2006;10(2): 111- 122 33.Zucker PK, Kasdon EJ, Feldstein ML. The validity of pap smear parameters as predictors of endometrial pathology in menopausal women. Cancer 1985;56:2256-63. 34.Nguyen TN, Bourdeau J, Ferenczy A, Franco EL. Clinical significance of histiocytes in the detection detection of endometrial adenocarcinoma and hyperplasia. Diagn Cytopathol 1998;19:89-93. 35.Paulette Mhawech-Fauceglia, Francois Herrmann, Wiam Bshara et al. Intraobserver and Interobserver Variability in Distinguishing Between Endocervical and Endometrial Adenocarcinoma on Problematic Cases of Cervical Curettings. International Journal of Gynecological Pathology 27:431–436 36.Han CP et al. Scoring of p16(INK4a) immunohistochemistry based on independent nuclear staining alone can sufficiently distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study. modern pathology. 2009 Jun;22(6):797-806. 37.Judit Pallares et al.CK2 Is Expressed in Endometrial Carcinoma and Has a Role in Apoptosis Resistance and Cell Proliferation.Am J Pathol 2009, 174:287–296 38.Wei-Ming Chien, Jacqueline N. Parker, Delf-Christian Schmidt-Grimminger et al. Casein Kinase II Phosphorylation of the Human Papillomavirus-18 E7 Protein Is Critical for Promoting S-Phase Entry. Cell Growth & Differentiation. 2000, August , Vol. 11, 425–435. 39.Paul K. S. Chan, Ching-Wan Lam, Tak-Hong Cheung et al. Association of Human Papillomavirus Type 58 Variant With the Risk of Cervical Cancer. J Natl Cancer Inst 2002;94:1249– 53 40.Aylin Simsir, Sonya Hwang, Joan Cangiarella et al .Glandular cell atypia on Papanicolaou smears: interobserver variability in the diagnosis and prediction of cell of origin. Cancer cytopathology, 2003 Dec 25;99(6):323-30 41.Charles J. Dunton, Management of Atypial glandular cell and adenocarcinoma in situ. Obstet Gynecol Clin N Am 35 (2008) 623–63 42.Schnatz PF, Guile M, O''Sullivan DM, Sorosky JI. Clinical significance of atypical glandular cells on cervical cytology. Obstet Gynecol 2006;107(3):701–8. 43. Salomão DR, Hughes JH, Raab SS. Atypical glandular cells of undetermined significance favor endometrial origin. Criteria for separating low grade endometrial adenocarcinoma from benign endometrial lesions. Acta Cytol, 2002 May-Jun;46(3):458-64. 44. Zhou J, Tomashefski J Jr, Khiyami A .Diagnostic value of the thin-layer, liquid-based Pap test in endometrial cancer: a retrospective study with emphasis on cytomorphologic features. Acta Cytol, 2007 Sep-Oct;51(5):735-41 45.國家衛生研究院,TCOG 子宮頸癌臨床治療指引 46.國家衛生研究院,TCOG 子宮內膜癌臨床治療指引 47. Kong CS, Balzer BL, Troxell ML, Patterson BK, Longaxre TA. p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia. Am J Sur Pathol,2007 Jan;31(1):33-43. 48. Stanley J. Robboy,George L. Mutter,Jaime Prat,Rex Bentley,Peter Russell. Robboy''s pathology of female reproductive tract.2009, Elsevier health sciences. 49. Anna Yemelyanova,MD,* Russell Vang,MD,*w Jeffrey D. Seidman,MD et al. Endocervical Adenocarcinomas With Prominent Endometrial or Endomyometrial Involvement Simulating Primary Endometrial Carcinomas. Am J Surg Pathol Volume 33, Number 6, June 2009. 50. Chiew-Loon Koo, Lai-Fong Kok, Ming-Yung Lee Han CP et al. Scoring mechanisms of p16INK4A immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study. Journal of Translational medicine, 2009, 7:25. 51. David W. LITCHFIELD.Protein kinase CK2: structure, regulation and role in cellular decisions of life and death.Biochem. J. (2003) 369, 1-15 52. A. M. Gown and A. M. Vogel.Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal human tissues.Am J Pathol. 1984 February; 114(2): 309–321 53. Ebell MH. Evidence-based diagnosis: a handbook of clinical prediction rules. Berlin, New York, Vienna: Springer, 2001.
|